Amgen

Amgen

World Rank (Jul-30-2023)
105
Market Cap (Jul-30-2023)
126.30 Billion USD
World Rank (Dec-25-2022)
80
Market Cap (Dec-25-2022)
140.82 Billion USD
World Rank (Jan-07-2022)
113
Market Cap (Jan-07-2022)
128.03 Billion USD
World Rank (Jan-01-2021)
91
Market Cap (Jan-01-2021)
133.85 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 63
Company Rank in Country in 2022
Rank in USA in 2022 is 67
World Region
Americas
World Subregion
Northern America
CEO
Robert A. Bradway
Chairman
Robert A. Bradway
Founders
George Rathmann
Employee Count
25,200
Employee Count as of Date
As on Dec-2022
Headquarters Country
USA
Headquarters City/State
California
Annual Revenue in USD
26,323 Million USD
Annual Operating Income in USD
9,566 Million USD
Annual Net Income in USD
6,552 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
65,121 Million USD
Total Liabilities in USD
61,460 Million USD
Total Equity in USD
3,661 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector LC
Healthcare
Pharmaceutical
Biopharmaceutical
Biotechnology
HealthCare Products
Company Website
Amgen Inc - Bio Technology Products Healthcare Company
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

Amgen believes in a “biology first” approach. Amgen use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Facts About Company

As on 2022, Amgen has 25,200 employees.

Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

Split of Annual Revenue by business segment  for period ending Dec-2021:

  • Product sales: 24,297 million USD.
  • Other revenues : 1,682 million USD.

Amgen annual net income generated for period ending Dec-2021 was 5,893 million USD.

Annual Results Summary LC

Amgen Inc - Yearly Results - Revenue and Net Profit - in Million USD:

Year - EndingRevenueNet Profit
Dec-202226,3236,552
Dec-202125,9795,893
Dec-202025,4247,264
Dec-201923,3627,842
Dec-201823,7478,394
Dec-201722,8491,979
Dec-201622,9917,722
Balance Sheet Summary LC

Amgen Inc - Balance Sheet Summary - in Million USD:

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-202265,12161,4603,661
Dec-202161,16554,4656.700
Dec-202062,94853,5399,409
Dec-201959,70750,0349,673
Dec-201866,41653,91612,500
Dec-201779,95454,71325,241
Dec-201677,62647,75129,875
Quarterly Results Summary LC

Amgen Inc - Quarterly Results - Revenue and Net Profit - in Million USD:

Quarter - EndingRevenueNet Profit
Sep-20236,9031,730
Jun-20236,9861,379
Mar-20236,1052,841
Dec-20226,8391,616
Sep-20226,6522,143
Jun-20226,5941,317
Mar-20226,2381,476
Dec-20216,8461,899
Sep-20216,7061,884
Jun-20216,526464
Mar-20215,9011,646
Dec-20206,6341,615
Sep-20206,4232,021
Jun-20206,2061,803
Mar-20206,1611,825
Dec-20196,1971,703
Sep-20195,7371,968
Jun-20195,8712,179
Mar-20195,5571,992
Dec-20186,2301,928
Sep-20185,9041,859
Founded Year
1980
Institutional Investors

Top 25 Institutional Investors in AMGEN as on SEP-30-2023

RANKINSTITUTION NAMEDATESHARES HELDCHANGE (SHARES)CHANGE (%)VALUE (IN 1,000S)
1VANGUARD GROUP INC09/30/20234,90,35,9811,65,6360.34%$13,388,294
2BLACKROCK INC.09/30/20234,75,74,8846,20,8311.32%$12,989,371
3STATE STREET CORP09/30/20232,85,75,487-5,23,394-1.80%$7,801,965
4PRIMECAP MANAGEMENT CO/CA/09/30/20231,47,32,458-3,977-0.03%$4,022,403
5MORGAN STANLEY09/30/20231,32,47,973-3,52,016-2.59%$3,617,094
6GEODE CAPITAL MANAGEMENT, LLC09/30/20231,21,37,4913,38,3082.87%$3,313,899
7CHARLES SCHWAB INVESTMENT MANAGEMENT INC09/30/20231,08,93,895-3,47,963-3.10%$2,974,360
8CAPITAL RESEARCH GLOBAL INVESTORS09/30/202384,93,209-10,76,582-11.25%$2,318,901
9WELLS FARGO & COMPANY/MN09/30/202375,81,419-89,294-1.16%$2,069,955
10NORTHERN TRUST CORP09/30/202369,77,6252,55,4633.80%$1,905,101
11PRICE T ROWE ASSOCIATES INC /MD/09/30/202363,20,99014,80,00130.57%$1,725,820
12BANK OF NEW YORK MELLON CORP09/30/202354,37,18261,5281.15%$1,484,514
13NORGES BANK12/31/202251,46,8853,51,3417.33%$1,405,254
14ROYAL BANK OF CANADA09/30/202350,79,6775,18,68911.37%$1,386,904
15JPMORGAN CHASE & CO09/30/202350,31,749-73,857-1.45%$1,373,818
16ARISTOTLE CAPITAL MANAGEMENT, LLC09/30/202343,53,169-1,43,898-3.20%$1,188,546
17BANK OF AMERICA CORP /DE/09/30/202341,88,285-2,24,940-5.10%$1,143,527
18LEGAL & GENERAL GROUP PLC09/30/202340,60,618-1,52,947-3.63%$1,108,671
19FMR LLC09/30/202336,38,551-3,04,584-7.72%$993,434
20GOLDMAN SACHS GROUP INC09/30/202335,66,4486,75,32823.36%$973,747
21INVESCO LTD.09/30/202333,56,3594,59,34015.86%$916,387
22UBS ASSET MANAGEMENT AMERICAS INC09/30/202333,05,650-2,775-0.08%$902,542
23NUVEEN ASSET MANAGEMENT, LLC09/30/202330,48,953-1,03,990-3.30%$832,456
24AMUNDI09/30/202329,57,1651,91,4856.92%$807,395
25UBS GROUP AG09/30/202329,16,520-3,34,740-10.30%$796,297
26DEUTSCHE BANK AG\09/30/202328,21,200-5,23,691-15.66%$770,272
27STATE FARM MUTUAL AUTOMOBILE INSURANCE CO09/30/202328,01,33100%$764,847
28FEDERATED HERMES, INC.09/30/202324,99,64426,0451.05%$682,478
29DIMENSIONAL FUND ADVISORS LP09/30/202324,13,12620,6740.86%$658,856
30CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM09/30/202322,25,54945,3842.08%$607,642
IPO Year
1983
Stock Category LC
S&P 500
Nasdaq 100
Dow Jones Index (DJIA)
Stock Exchange LC
Nasdaq
Mexico